Medroxyprogesterone is a progestin and is common component of oral contraceptives for women.
Progestins decrease the risk of Estrogen caused or associated uterus cancers.
1.) Abnormal menstrual bleeding
4.) Hormone Replacement Therapy
When used in combination with estrogen – may increase risk for Heart Attack, Stroke, blood clots found in lungs [Pulmonary Embolism] or legs.
If used for menopause in combination with estrogen then the usage should be expected for only a short period of time
– Weight gain
– Change in menses
Pregnancy – do not use in first 4 months